acyltetramides has been prepared via a nitrile oxide dipolar cycloaddition approach, as analogues of the acyltetramic acid metabolite reutericyclin, of interest for their antibiotic potential against Gram-positive bacteria including hospitalacquired infections of resistant Clostridium difficile. 10 In order to combat the growing resistance to generally administered antibiotics, such as penicillin and methicillin, the research community is endeavouring to find new compounds that actively inhibit problematic resistant bacteria. 1 This effort has identified a number of potential candidates, one example of 15 which is reutericyclin (1), isolated in 2000 by Jung et al. from Lactobacillius reuteri LTH2584. 2 Reutericyclin belongs to the 3-acyltetramic acid group of natural products (2) , characterised by a pyrrolidine-2,4-dione unit carrying an acyl group at C-3. 3 Molecules containing this motif exhibit a range of bio-activities 20 including antibiotic, antitumor, antiviral, antiulcerative, fungicidal and cytotoxic properties. 4 Interest in the antibiotic activity of tetramic acids has recently been stimulated by their key relationship to the inducers of bacterial quorum sensing. 5 Reutericyclin and derivatives display varying inhibition in Gram-25 positive bacteria. 2, 6 The most interesting of these results is the inhibition of growth of resistant bacterium Clostridium difficile, a leading cause of antibiotic-associated diarrhoea in hospitalized patients which can lead to mortalities in persons with a compromised immune system. 7 30 We have, over many years, explored the synthesis of the acyltetramic acid moiety 8 and other cyclic tricarbonyl systems, 9 most recently using pyrroloisoxazoles as masked acyltetramic acids and as core building blocks for peripheral elaboration. The commercially available methyl esters of S-valine, Sleucine and S-phenylglycine were efficiently N-protected (Boc 2 O, 50 Et 3 N, CH 2 Cl 2 , 0-20 ºC; 99, 97 and 99%, respectively). The protected amino esters (5a-c, respectively) were selectively reduced to the corresponding aldehydes using DIBAL-H at -78 ºC (91, 93 and 87%), which were converted directly to the oximes 6a-c (H 2 NOH.HCl, NaOAc, aq. EtOH, 2-8 ºC; 86, 79 and 88%) 55 to inhibit potential epimerisation (Scheme 2). Treatment with NCS (CHCl 3 reflux) afforded C-chloro-oximes 7, either used directly (7a,c) or isolated (7b; 75%); an extended reaction time for chlorination (18 h) led to better results when using the hydroximoyl chlorides 7 (vide infra) than in our previous reports. The key dipolar cycloaddition step was performed by addition of Et 3 N to the chloro-oximes in the presence of the pyrrolidine enamine of tert-butyl acetoacetate and pyrrolidine (separately prepared; toluene reflux, Dean-Stark conditions; 99%) to form the nitrile oxide in situ and complete the cycloaddition (CHCl 3 reflux) to afford isoxazoles 8a,c (49 and 56% from 6a,c) and 8b (60% from 7b). Simultaneous deprotection of the N-Boc amine 5 and tert-butyl ester cleavage was achieved by acid treatment (TFA, 20 ºC; then 2M aq. HCl to give hydrochloride salts of better stability for handling and on storage) to leave amino acid salts 9a-c (99, 70 and 68%).
The final stage in assembly of the pyrroloisoxazoles, closure of 10 the pyrrolo ring, was initially completed by our previously reported method using N-[3-(dimethylamino)propyl]-N'-ethylcarbodiimide hydrochloride (EDCI) (N-hydroxysuccinimide, Et 3 N, DMF, 0-20 ºC) which required column chromatography and yielded the pyrroloisoxazoles 10a,b in unreliable yields 15 (ranging 8-60%).
10b Other peptide coupling reagents were investigated: whilst PyBroP failed, HATU did produce 10a in 40% yield.
14 The variable performance could be improved by using a polystyrene-supported carbodiimide (supplied as PS-CDI; Argonaut Technologies™) (Et 3 N, DMF-CH 2 Cl 2 , 20 ºC, 17 h) that 20 reliably afforded 10a (66%), still however requiring column chromatographic purification and a costly alternative. Finally the simplest and most reliable lactam closure was achieved using the recently commercialised cyclic propylphosphonic anhydride (supplied as T3P; Archemica™). 15 Thus a base (Et 3 N) was added 25 to the salts 10a,b in EtOAc followed by T3P (0-20 ºC, 17 h). The pyrroloisoxazoles 10a,b were isolated pure without needing chromatography in good yields (59 and 68%). The phenylglycine-derived 10c was unsuccessful with T3P but could be prepared reliably by the PS-CDI protocol (50%). We have thus 30 revealed two improved protocols for lactam closure to pyrroloisoxazoles 10: using T3P or PS-CDI. The last stage in the synthesis of the masked reutericyclin analogues was to perform an N-acylation. As base we selected to use BuLi (THF, -78 ºC). Carboxylic esters were investigated as 35 acylating agents but without success. However, acyl chlorides proved to be effective acylating agents to produce the N-acyl derivatives 11 (Scheme 3). 13 A variety of acyl chlorides were selected including long and short aliphatic chains, an α,β-unsaturated chain, a hindered branched moiety and an aromatic 40 substituent, and all afforded N-acyl products 11 in yields of 33-97% (Table 1) . † Longer chain, aromatic or more hindered acyl chlorides required a slightly longer time for complete reaction than the shorter, unhindered, examples; a standard reaction time of 3 h was eventually employed. The constitution of the N-(but-2-45 enyl)-6-(2-methylpropyl)pyrroloisoxazole 11c was confirmed by an X-ray crystal structure (Fig. 1) . ‡ This completed the synthesis of the reutericyclin analogues. 55 Next we determined to create some tetramide analogues, by N-O bond cleavage of the pyrroloisoxazole nucleus. This was achieved for bicycles 11a,f by hydrogenolysis (1 atm H 2 , Pd-C) to afford the enaminoketones (tetramides) 12a,b (49 and 52%) (Scheme 4). To demonstrate an alternative protocol, and because 60 hydrogenation would be likely to reduce an unsaturated N-acyl group, 10b N-O cleavage of 11l was accomplished by Mo(CO) 6 (aq. MeCN; then 2M aq. HCl) to give enaminoketone 12c (60%). 16 Attempted hydrolysis of the enamine to generate acyltetramic acid either returned unchanged enaminoketone (e.g. 65 H 2 O at 20 ºC or 2M aq. HCl at reflux; NaNO 2 , 3M aq. H 2 SO 4 ) or led to N-deacylation (aq. NaOH, 2M at reflux or 0.1M at 20 ºC). 
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